Literature DB >> 189372

Pathogenesis of radiation and virus-induced bone tumors.

M P Finkel, C A Reilly, B O Biskis.   

Abstract

Bone cancer can be induced by radionuclides that localize in the skeleton. Histologically, these experimentally induced tumors resemble those found naturally in man; they range from densely ossified osteogenic sarcomas to osteolytic tumors with giant cells and only a small osteoid component. Fibrosarcomas and hemangiosarcomas also can occur in some species. It has not been possible to determine the dose in terms of absorbed energy necessary for bone-tumor induction because radionuclides are not deposited uniformly, and they diminish in amount with time. Also, the precise time when irreversible noeplastic change occurs is not known. With X-rays, however, 500 rads delivered to the endosteal surface of a mouse femur has been shown to cause osteogenic sarcoma. Bone tumors can be induced in mice by viruses. FBJ osteosarcoma virus and RFB osteoma virus were obtained from spontaneous tumors; FBR osteosarcoma virus came from a radiation-induced tumor. All three are RNA viruses with C-type particle morphology, and they are propagated by injecting cell-free extracts of virus-induced tumor. All three are RNA viruses with C-type particle morphology, and they are propagated by injecting cell-free extracts of virus-induced tumor into newborn mice. Interaction studies with bone-seeking radionuclides and these viruses have led to the hypothesis that radiation produces cancer by inactivating a viral inhibitor. There is also evidence of a bone tumor virus in the human disease. The injection of cell-free extracts of human bone cancer into newborn Syrian hamsters has induced a variety of mesenchymal tumors at a rate significantly higher than in the control hamsters. Sixty tumors of this type, including 20 osteosarcomas, 11 fibrosarcomas, and 9 osteomas, have been diagnosed so far in experimental animals; in control hamsters there has been only one, a fibrosarcoma. Immunofluorescence assays and cytotoxicity studies indicated that these hamster tumors carried a human antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 189372     DOI: 10.1007/978-3-642-80997-2_7

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  6 in total

1.  Osteosarcomagenesis: modeling cancer initiation in the mouse.

Authors:  Kevin B Jones
Journal:  Sarcoma       Date:  2011-02-20

Review 2.  Osteosarcoma (osteogenic sarcoma).

Authors:  Piero Picci
Journal:  Orphanet J Rare Dis       Date:  2007-01-23       Impact factor: 4.123

3.  The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer.

Authors:  Manuela Malsy; Bernhard Graf; Katrin Almstedt
Journal:  BMC Biochem       Date:  2019-01-29       Impact factor: 4.059

4.  Downregulated RPS-30 in Angiostrongylus cantonensis L5 plays a defensive role against damage due to oxidative stress.

Authors:  Wei-Wei Sun; Xiu-Mei Yan; Qing Shi; Yuan-Jiao Zhang; Jun-Ting Huang; Hui-Cong Huang; Hong-Fei Shi; Bao-Long Yan
Journal:  Parasit Vectors       Date:  2020-12-09       Impact factor: 3.876

5.  Isolation of genes controlling apoptosis through their effects on cell survival.

Authors:  Gwyn T Williams; Jane P Hughes; Victoria Stoneman; Claire L Anderson; Nicola J McCarthy; Mirna Mourtada-Maarabouni; Mark Pickard; Vanessa L Hedge; Ian Trayner; Farzin Farzaneh
Journal:  Gene Ther Mol Biol       Date:  2006-12-12

6.  Detection of somatostatin receptors in human osteosarcoma.

Authors:  Markos Ioannou; Panayiotis J Papagelopoulos; Ioannis Papanastassiou; Ioanna Iakovidou; Stamatios Kottakis; Nikolaos Demertzis
Journal:  World J Surg Oncol       Date:  2008-09-10       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.